Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 7:41 AM
Study NCT ID:
NCT07392658
Status:
RECRUITING
Last Update Posted:
2026-02-06
First Post:
2025-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.
Sponsor:
Fondazione Ricerca Traslazionale
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-02
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-24
First Submit QC Date:
None
Study First Post Date:
2026-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-05
Last Update Post Date:
2026-02-06
Last Update Post Date Type:
ACTUAL